Blog

Governance Transition FAQs

 

Despite Headline Risks, Disclosure on Drug Pricing Remains Limited for Pharmaceuticals Companies

 

Moving from Provisional to Codified: An Update on the Consultation Period

 

Midnight Voyage: Where Ships Go to Die

 

Managing Director at HSBC Securities Shares His FSA Experience

 

Pipeline to Nowhere: Dakota Access and the Rights of Indigenous Peoples

 

Fake News Is Nothing Newsworthy

 

Alan Beller Pens Foreword to Inaugural Annual State of Disclosure Report

 

Refrigerants No Longer Cool – Countries Agree to Phase Out HFCs

 

Black Friday: The Financial Costs of Fast Fashion